SCHEMBL7209162

SCHEMBL7209162

Cc1csc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc(Oc4ccccc4)c3)[nH]2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.55
MAPK13 O15264 11/20 0.50
MAPK12 P53778 11/20 0.50
MAPK11 Q15759 11/20 0.50
GCGR P47871 9/20 0.50
ALOX5 P09917 4/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CSNK1D P48730 2/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
FRK P42685 1/20 0.41
MAPK9 P45984 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4584932 0.85 MAPK14 (0.46) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL7209158 0.81 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4553347 0.79 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL7206018 0.79 ALOX5 (0.64) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4554967 0.77 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13712660 0.76 MAPK14 (0.83) MAPK14MAPK13MAPK12MAPK11
SCHEMBL4586521 0.76 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4553295 0.74 MAPK13 (0.58) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4585131 0.72 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11CSNK1D
SCHEMBL4460400 0.71 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994870-A4 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM (US) 2002-10-23 EP claimed
EP-0994870-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS Smithkline Beecham (US) 2000-04-26 EP claimed
WO-1998057966-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-12-23 WO claimed
US-6610695-B1 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease SMITHKLINE BEECHAM CORPORATION 2003-08-26 US disclosed
EP-0994870-A4 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM (US) 2002-10-23 EP disclosed
EP-0994870-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS Smithkline Beecham (US) 2000-04-26 EP disclosed
WO-1998057966-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-12-23 WO disclosed